CRP and rheumatoid arthritis: Kaplan-Meier curves for the overall drug continuation rate and drug discontinuation rates due to AEs in patients with RA with high disease activity (DAS28-CRP > 4.1) versus those without high disease activity for each JAKi are shown in S1 and S2 Figs, respectively.